TGFBR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.585200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.605600E-01
Normal-vs-Stage2
8.953400E-01
Normal-vs-Stage3
2.534800E-01
Normal-vs-Stage4
3.885400E-01
Stage1-vs-Stage2
9.070400E-01
Stage1-vs-Stage3
1.223810E-01
Stage1-vs-Stage4
2.539000E-01
Stage2-vs-Stage3
1.314810E-01
Stage2-vs-Stage4
2.548400E-01
Stage3-vs-Stage4
3.855800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.803800E-01
Normal-vs-AfricanAmerican
7.222400E-01
Normal-vs-Asian
6.225600E-01
Caucasian-vs-AfricanAmerican
4.813600E-01
Caucasian-vs-Asian
1.871590E-01
AfricanAmerican-vs-Asian
2.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.491000E-01
Normal-vs-Female
8.706800E-01
Male-vs-Female
3.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.223800E-01
Normal-vs-Age(41-60Yrs)
6.271800E-01
Normal-vs-Age(61-80Yrs)
8.581800E-01
Normal-vs-Age(81-100Yrs)
5.426600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.979400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.518600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.297000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.358140E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.595800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.038600E-01
Normal-vs-Daily Drinker
7.672800E-01
Normal-vs-Weekly Drinker
8.301800E-01
Normal-vs-Occasional Drinker
8.033800E-01
Normal-vs-Social Drinker
9.407400E-01
Non Drinker-vs-Daily Drinker
9.256200E-01
Non Drinker-vs-Weekly Drinker
9.601200E-01
Non Drinker-vs-Occasional Drinker
9.884800E-01
Non Drinker-vs-Social Drinker
5.461000E-01
Daily Drinker-vs-Weekly Drinker
8.990000E-01
Daily Drinker-vs-Occasional Drinker
9.204400E-01
Daily Drinker-vs-Social Drinker
5.174800E-01
Weekly Drinker-vs-Occasional Drinker
9.720200E-01
Weekly Drinker-vs-Social Drinker
6.439000E-01
Occasional Drinker-vs-Social Drinker
5.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.917800E-01
Normal-vs-Grade 2
9.153800E-02
Normal-vs-Grade 3
3.358000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.637780E-02
Grade 1-vs-Grade 3
2.153800E-02
Grade 1-vs-Grade 4
2.917800E-01
Grade 2-vs-Grade 3
7.127400E-01
Grade 2-vs-Grade 4
9.153800E-02
Grade 3-vs-Grade 4
3.358000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.186800E-01
Normal-vs-NonDiabetic
7.849600E-01
Diabetic-vs-NonDiabetic
2.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.631800E-01
Normal-vs-NoPancreatitis
9.134800E-01
Pancreatitis-vs-NoPancreatitis
9.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.665200E-01
Normal-vs-N1
8.423200E-01
N0-vs-N1
1.927220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.197400E-01
Normal-vs-TP53-NonMutant
8.833400E-01
TP53-Mutant-vs-TP53-NonMutant
8.179800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
